Swiss (SMI) Pharmaceuticals & Biotech Dividend Stocks

UPDATED Nov 16, 2025

Discover Swiss Pharmaceuticals & Biotech High Yield Dividend Stocks that are on the SMI and sorted by Dividend Yield. An upper limit of 20% is in place to filter out stocks with potentially unsustainable dividends. All companies with high dividend yields (above 5%) should be researched for sustainability. For more options please click on 'Advanced Filters'.

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
ROG
Roche Holding
CHF 286.102.6%12.9%CHF 245.5bCHF 300.00PE25.8xE12.5%3.4%
NOVN
Novartis
CHF 104.422.2%14.5%CHF 200.4bCHF 102.78PE17.5xE7.7%2.9%
COPN
Cosmo Pharmaceuticals
CHF 65.102.0%3.8%CHF 1.0bCHF 87.46PE18.7xE35.2%2.9%
TECN
Tecan Group
CHF 140.005.1%-33.0%CHF 1.8bCHF 202.48PE28.2xE16.2%2.1%
BANB
Bachem Holding
CHF 50.80-0.8%-25.8%CHF 3.8bCHF 74.69PE28.4xE16.9%1.7%
SDZ
Sandoz Group
CHF 54.841.9%37.9%CHF 23.6bCHF 51.64PE131.1xE29.8%1.0%
SKAN
SKAN Group
CHF 47.85-1.7%-32.6%CHF 1.1bCHF 74.00PE66.5xE31.6%0.8%
LONN
Lonza Group
CHF 544.401.9%7.2%CHF 38.2bCHF 677.55PE52.2xE20.5%0.7%
SFZN
Siegfried Holding
CHF 75.000.4%-31.6%CHF 3.3bCHF 110.07PE21.3xE11.0%0.5%
GALD
Galderma Group
CHF 149.501.5%75.5%CHF 35.5bCHF 150.37PE118.3xE30.8%0.09%
DESN
Dottikon ES Holding
CHF 313.001.0%34.6%CHF 4.3bCHF 357.63PE41xS12.7%0%
BSLN
Basilea Pharmaceutica
CHF 46.853.3%17.7%CHF 575.7mCHF 90.78PE7.9xE-25.4%0%
PPGN
PolyPeptide Group
CHF 23.750.8%-12.5%CHF 783.5mCHF 34.35PS2.3xE65.3%0%